Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Linköping
Clinical trial register · Sweden

Clinical Trials in Linköping, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2221 matching records held by the registry are in this view. Synced 18 Nov 2026, 03:18 UTC
2221
Studies in scope
all four open statuses
1241
Recruiting now
open to new participants
366
Lead sponsors
across recruiting studies
Top sites
Stockholm 32 Uppsala 25 Lund 20 Gothenburg 19 Linköping 15
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Linkoeping University41 Karolinska Institutet16 AstraZeneca15 University Hospital, Linkoeping12 Uppsala University8 Vastra Gotaland Region6 Region Östergötland6 Janssen Research & Development, LLC5 Merck Sharp & Dohme LLC5 Karolinska University Hospital4 Region Skane4 Boehringer Ingelheim4 Ostergotland County Council, Sweden3 Takeda3 Göteborg University3 Mats Heyman2 University Hospital Muenster2 Amgen2 Lund University Hospital2 Region Stockholm2 Pfizer2 Bristol-Myers Squibb2 Nordic Lymphoma Group2 Sanofi2 Maastricht University2 Gustave Roussy, Cancer Campus, Grand Paris2 Norwegian University of Science and Technology2 AbbVie2 GlaxoSmithKline2 Genmab2 Region Jönköping County2 pharmaand GmbH1 Maastricht University Medical Center1 Sahar Salehi1 Alpine Immune Sciences Inc, A Subsidiary of Vertex1 Johnny Ludvigsson1 Esteve Pharmaceuticals, S.A.1 Newcastle University1 Oslo University Hospital1 Gedea Biotech AB1 Viatris Innovation GmbH1 Jannet Svensson1 Catholic University of the Sacred Heart1 Daniel Wilhelms1 Jon Unosson1 Universitat Internacional de Catalunya1 Johan Kihlberg1 EMD Serono Research & Development Institute, Inc.1 Katarina Hedin1 Stichting European Myeloma Network1 University Medical Center Groningen1 Uppsala University Hospital1 Raija Silvennoinen1 Anna Martling1 University of Oxford1 Region Örebro County1 Diagram B.V.1 Princess Maxima Center for Pediatric Oncology1 Medical University of Vienna1 Skane University Hospital1 Incyte Corporation1 The Christie NHS Foundation Trust1 Kartos Therapeutics, Inc.1 The Cleveland Clinic1 University of Aarhus1 Wake Forest University Health Sciences1 John Neoptolemos1 Alexander Valdman1 Hans Bahlmann1 Lina Bergman1 Sahlgrenska University Hospital1 Brainsway1 United Therapeutics1 Tesaro, Inc.1 University of Dublin, Trinity College1 Olof Akre1 Sofia Ramström1 Oulu University Hospital1 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1 Hoffmann-La Roche1 Universitätsklinikum Hamburg-Eppendorf1 Windward Bio1 Alentis Therapeutics AG1 Odense University Hospital1 Johan Virhammar1 MedImmune LLC1 Malmö University1 Copenhagen University Hospital, Rigshospitalet1 Eli Lilly and Company1 Celgene1 Thomas Abrahamsson, MD, PhD1 Novartis Pharmaceuticals1 Mattias Ekstedt1 German CLL Study Group1 Clear sponsor filter
Target enrolment
to

Trials with a site in Linköping

15 of 2221 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Recruiting
AstraZeneca
Phase 3
500
Linköping, Lund, Mölndal, Örebro, Stockholm
2026-08-24
Recruiting
AstraZeneca
Phase 3
7,000
Falun, Gothenburg, Karlstad, Linköping, Lund, Örebro, Stockholm, Uppsala
2026-08-21
Recruiting
AstraZeneca
Phase 3
1,100
Linköping, Lund, Solna, Umeå, Uppsala
2025-12-29
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
AstraZeneca
Phase 3
473
Gothenburg, Linköping, Lund, Stockholm, Uppsala
2025-06-10
Recruiting
AstraZeneca
Phase 3
5,000
Huddinge, Karlstad, Linköping, Stockholm, Uppsala, Vaxjo
2025-03-03
Active, closed
AstraZeneca
Phase 2
24
Linköping, Stockholm
2024-12-11
Active, closed
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
NCT06450197Moderate to Severe Crohn's Disease
AstraZeneca
Phase 2
120
Linköping, Stockholm
2024-08-28
Active, closed
AstraZeneca
Phase 3
2,554
Gävle, Gothenburg, Linköping, Rättvik, Stockholm, Uppsala
2024-03-29
Active, closed
AstraZeneca
Phase 3
1,835
Gothenburg, Linköping, Rättvik, Stockholm, Uppsala
2023-11-07
Active, closed
AstraZeneca
Phase 3
953
Eskilstuna, Linköping, Stockholm, Uppsala
2015-11-03
Active, closed
AstraZeneca
Phase 3
682
Linköping
2015-10-21
Active, closed
AstraZeneca
Phase 3
1,837
Gothenburg, Linköping, Malmö, Solna, Stockholm, Umeå
2014-04-22
Active, closed
AstraZeneca
Phase 3
510
Linköping, Örebro, Uppsala
2013-09-25
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 November 2026. https://priyalifescience.com/clinical-trials-sweden/city/link-ping

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,221 studies in total at the last sync on 18 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies with a site in Linköping that also match the filters currently applied.

How many clinical trials are recruiting in Linköping?

5 of the 15 studies on this page are recruiting new participants as of the 18 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Linköping), 15 studies
PhaseStudiesRecruitingShare
Phase 313586.7%
Phase 22013.3%

Most active sponsors

Lead sponsors with the most studies (Linköping)
Lead sponsorStudiesRecruiting
AstraZeneca155
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.